TScan Therapeutics (TCRX) Prepaid Assets (2020 - 2026)

TScan Therapeutics (TCRX) has 7 years of Prepaid Assets data on file, last reported at $4.7 million in Q1 2026.

• On a quarterly basis, Prepaid Assets rose 49.63% year-over-year to $4.7 million in Q1 2026; TTM through Mar 2026 was $4.7 million, a 49.63% increase from a year earlier, with the FY2025 full-year figure at $4.8 million, up 83.84% from the prior year.
• Prepaid Assets for Q1 2026 stood at $4.7 million, down from $4.8 million in the prior quarter.
• Over the last five years, Prepaid Assets for TCRX reached as high as $5.3 million in Q1 2023 and fell as low as $1.4 million in Q2 2023.
• Historically, Prepaid Assets has averaged $3.3 million across 5 years, with a median of $3.1 million in 2025.
• Across the five-year window, Prepaid Assets plunged 63.43% in 2024 and surged 83.84% in 2025, its largest moves.
• Year by year, Prepaid Assets stood at $4.1 million in 2022, then plunged by 46.51% to $2.2 million in 2023, then advanced by 19.11% to $2.6 million in 2024, then jumped by 83.84% to $4.8 million in 2025, then fell by 1.94% to $4.7 million in 2026.
• Per Business Quant data, the three most recent Prepaid Assets figures were $4.7 million in Q1 2026, $4.8 million in Q4 2025, and $3.7 million in Q3 2025.